22.47
1.75%
-0.40
Enliven Therapeutics Inc (ELVN) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Revenues |
-
|
- | - | - | - |
Operating Expenses
|
14.33%
25.99
|
22.73 | 24.25 | 20.13 | 16.42 |
Operating Income/Loss |
14.33%
-25.99
|
-22.73 | -24.25 | -20.13 | -16.42 |
Nonoperating Income/Loss |
3.27%
3.249
|
3.359 | 3.479 | 3.413 | 1.694 |
Income/Loss From Continuing Operations Before Tax |
17.39%
-22.74
|
-19.37 | -20.77 | -16.72 | -14.72 |
Income/Loss From Continuing Operations After Tax |
17.39%
-22.74
|
-19.37 | -20.77 | -16.72 | -14.72 |
Net Income/Loss
|
17.39%
-22.74
|
-19.37 | -20.77 | -16.72 | -14.72 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
2,135%
42.05
|
1.8811 | 41.03 | 40.96 | 18.51 |
Diluted Average Shares |
2,135%
42.05
|
1.8811 | 41.03 | 40.96 | 18.51 |
Basic Earnings Per Share |
17.39%
-0.54
|
-0.46 | -0.51 | -0.41 | -0.80 |
Diluted Earnings Per Share |
17.39%
-0.54
|
-0.46 | -0.51 | -0.41 | -0.80 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):